1. GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer
    Dai Shimizu et al, 2017, Scientific Reports CrossRef
  2. Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer
    Mitsuro Kanda et al, 2014, Journal of Experimental & Clinical Cancer Research CrossRef
  3. B-cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma
    MITSURO KANDA et al, 2015, International Journal of Oncology CrossRef
  4. Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor
    Hisaharu Oya et al, 2015, Journal of Gastroenterology CrossRef
  5. Association of TUSC1 and DPF3 gene polymorphisms with male infertility
    Youichi Sato et al, 2018, Journal of Assisted Reproduction and Genetics CrossRef
  6. DNA methylation-mediated suppression of TUSC1 expression regulates the malignant progression of esophagogastric junction cancer
    Zhiqiang Liu et al, 2024, Clinical Epigenetics CrossRef
  7. Tumor Suppressor Candidate 1 Suppresses Cell Growth and Predicts Better Survival in Glioblastoma
    Rui Zhang et al, 2017, Cellular and Molecular Neurobiology CrossRef
  8. Combined treatment of human multiple myeloma cells with bortezomib and doxorubicin alters the interactome of 20S proteasomes
    Alexey G. Mittenberg et al, 2018, Cell Cycle CrossRef
  9. YARG: A repository for arsenic-related genes in yeast
    Jagat Rathod et al, 2018, PLOS ONE CrossRef
  10. Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer
    Dai Shimizu et al, 2018, World Journal of Gastrointestinal Oncology CrossRef
  11. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma
    Satoshi Sueoka et al, 2015, Annals of Surgical Oncology CrossRef
  12. Prognostic relevance of SAMSN1 expression in gastric cancer
    Mitsuro Kanda et al, 2016, Oncology Letters CrossRef
  13. Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma
    Mitsuro Kanda, 2015, World Journal of Gastroenterology CrossRef
  14. Arsenic-gene interactions and beta-cell function in the Strong Heart Family Study
    Poojitha Balakrishnan et al, 2018, Toxicology and Applied Pharmacology CrossRef
  15. Translational implication of Kallmann syndrome-1 gene expression in hepatocellular carcinoma
    YURI TANAKA et al, 2015, International Journal of Oncology CrossRef
  16. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
    Kazuhiro Ezaka et al, 2015, Annals of Surgical Oncology CrossRef
  17. Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma
    MITSURO KANDA et al, 2014, International Journal of Oncology CrossRef
  18. Search for useful biomarkers in hepatocellular carcinoma, tumor factors and background liver factors
    Dai Shimizu et al, 2017, Oncology Reports CrossRef
  19. Intrahepatic recurrence of hepatocellular carcinoma after resection: an update
    Maria Tampaki et al, 2021, Clinical Journal of Gastroenterology CrossRef